Zhitong Finance App News, Sinopharm Holdings (01099) announced that in the first three quarters of 2026, Sinopharm shares (600511.SH) achieved revenue of about 40.606 billion yuan, up 3.11% year on year; net profit attributable to shareholders of listed companies was about 1,476 billion yuan, a decrease of 1.07% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was about 1,475 billion yuan, up 0.36% year on year; basic income per share was 1.9566 yuan.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.